SCHOTT Pharma AG & Co. KGaA | WebDisclosure

Basculer en Français

10700	Companies
228732	Keywords
157372	Articles
121430	Press releases

Headlines Articles Press releases SCHOTT Pharma AG & Co. KGaA

Home
Companies
SCHOTT Pharma AG & Co. KGaA

BRIEF

published on 07/08/2026 at 18:50, 1 hour 41 minutes ago

SCHOTT Pharma publie ses résultats du troisième trimestre et revoit ses prévisions à la hausse pour 2026.

Croissance Des Revenus Marge D'EBITDA Orientations Pour 2026 Résultats Du Troisième Trimestre 2026 Accord Sur Les Seringues En Verre
BRIEF

published on 07/08/2026 at 18:50, 1 hour 41 minutes ago

SCHOTT Pharma Releases Q3 Figures, Increases 2026 Forecast

Revenue Growth EBITDA Margin 2026 Guidance Q3 2026 Results Glass Syringes Agreement
PRESS RELEASE

published on 07/08/2026 at 18:45, 1 hour 46 minutes ago

EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance
SCHOTT Pharma AG & Co. KGaA raises 2026 revenue and earnings guidance based on strong Q3 performance and key customer agreement. Preliminary figures show 8% revenue growth and 27% EBITDA margin

SCHOTT Pharma Earnings Guidance Q3 Performance 2026 Revenue Key Customer Agreement
BRIEF

published on 05/13/2026 at 07:05, 1 month 26 days ago

SCHOTT Pharma annonce un premier semestre résilient et un flux de trésorerie solide

SCHOTT Pharma Croissance Des Revenus Marge D'EBITDA Des Flux De Trésorerie Résultats De La Première Mi-temps
BRIEF

published on 05/13/2026 at 07:05, 1 month 26 days ago

SCHOTT Pharma Reports Resilient First Half and Strong Cash Flow

Revenue Growth Cash Flow EBITDA Margin SCHOTT Pharma First Half Results
PRESS RELEASE

published on 05/13/2026 at 07:00, 1 month 26 days ago

SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow
SCHOTT Pharma reports robust first half with strong cash flow, exceeding revenue forecast and confirming full-year outlook for 2026

Financial Results Revenue Cash Flow SCHOTT Pharma H1 2026
BRIEF

published on 02/11/2026 at 07:05, 4 months 25 days ago

SCHOTT Pharma Reports a Strong Beginning to 2026

Revenue Increase SCHOTT Pharma EBITDA Growth Financial Year 2026 Drug Containment Solutions
BRIEF

published on 02/11/2026 at 07:05, 4 months 25 days ago

SCHOTT Pharma annonce un bon début d'année 2026

SCHOTT Pharma Augmentation Des Revenus Croissance De L'EBITDA Exercice Financier 2026 Solutions De Confinement Des Médicaments
PRESS RELEASE

published on 02/11/2026 at 07:00, 4 months 25 days ago

SCHOTT Pharma with positive start to financial year 2026; outlook confirmed
SCHOTT Pharma reports positive Q1 results for 2026 with revenue growth and increased EBITDA margin. Outlook confirmed for the year

Revenue Growth EBITDA Margin SCHOTT Pharma Q1 Results 2026 Outlook
BRIEF

published on 02/03/2026 at 15:05, 5 months 5 days ago

All Resolutions Passed at SCHOTT Pharma's AGM

Shareholders Dividend Pharmaceutical AGM Resolutions

Accesswire

Published on 07/08/2026 at 16:45, 3 hours 46 minutes ago

Change Of Record Date for Special Meeting
Published on 07/08/2026 at 15:25, 5 hours 6 minutes ago

Rockhaven Announces Granting of Incentive Stock Options
Published on 07/08/2026 at 15:00, 5 hours 31 minutes ago

Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative
Published on 07/08/2026 at 15:00, 5 hours 31 minutes ago

GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report
Published on 07/08/2026 at 14:30, 6 hours 1 minute ago

Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily

View all ACCESSWIRE

EQS Group

Published on 07/08/2026 at 19:45, 46 minutes ago

NNS acquires shares in OCI
Published on 07/08/2026 at 19:42, 49 minutes ago

EQS-Adhoc: SMAG Mobile Antenna Masts AG sets final offer price for initial public offering (IPO) at EUR 46 per share
Published on 07/08/2026 at 18:52, 1 hour 38 minutes ago

namR: PRONONCÉ DE LA LIQUIDATION JUDICIAIRE DE LA SOCIÉTÉ SA NAM.R
Published on 07/08/2026 at 18:45, 1 hour 46 minutes ago

EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance
Published on 07/08/2026 at 18:17, 2 hours 14 minutes ago

Dividend announcement

Les Echos

Published on 07/08/2026 at 20:00, 31 minutes ago

ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 07/08/2026 at 20:00, 31 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 07/08/2026 at 20:00, 31 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JUIN 2026
Published on 07/08/2026 at 20:00, 31 minutes ago

ALTAREA - DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JUIN 2026
Published on 07/08/2026 at 20:00, 31 minutes ago

ALTAREIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE

View all LES ECHOS COMFI WIRE